Files
Publication Date
9-2025
Disclaimer
These guidelines do not establish a standard of care to be followed in every case. It is recognized that each case is different and those individuals involved in providing health care are expected to use their judgment in determining what is in the best interests of the patient based on the circumstances existing at the time. It is impossible to anticipate all possible situations that may exist and to prepare guidelines for each. Accordingly, these guidelines should guide care with the understanding that departures from them may be required at times.
Objective of the Clinical Pathway
To provide care standards for the patient who presents with suspected opioid withdrawal or potential opioid use disorder. The Opioid Withdrawal Treatment Clinical Pathway aims to provide decision support and considerations for how to prescribe buprenorphine/naloxone (Suboxone) to adolescents and young adults safely when addressing opioid withdrawal.
Target Users
Physicians (Emergency Medicine, Urgent Care, Hospital Medicine, Adolescent and Young Adult Medicine, Developmental and Behavioral Health, Residents, Fellows); Advanced Practice Providers; Nursing; Pharmacy; Social Work
Disciplines
Pediatrics
Recommended Citation
Children's Mercy Kansas City, "Opioid Withdrawal Treatment: Buprenorphine/Naloxone (Suboxone)" (2025). Clinical Pathways.
https://scholarlyexchange.childrensmercy.org/clinical_pathways/39
